Mark Waskiewicz

Mark Waskiewicz is an experienced professional in the biopharmaceutical industry, with a career spanning from October 1995 to the present. Early positions included roles at Merck & Co., Inc. as a Regulatory Coordinator and Senior Research Biochemist focusing on analytical development and regulatory support for vaccine products. Waskiewicz further progressed to leadership roles, including Vice President and Head of Vaccine Technical Development at Takeda, overseeing CMC development and clinical trial materials for vaccine programs. Additional experience includes serving as Senior Director of Global Head Vaccine Regulatory Affairs CMC at Bristol Myers Squibb and Associate Director of Biologics CMC at Merck Sharp & Dohme. Waskiewicz currently leads development and commercialization efforts in CMC at Merck. Waskiewicz holds a Master of Science degree from Rutgers Robert Wood Johnson Medical School and a Bachelor of Science from the University of the Sciences in Philadelphia.